ArticleOncotarget2017

A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer.

Xiao-Fang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.